Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arena Falls, Pulls Anti-Obesity Application In Europe
Seeking Alpha
Friday, May 3, 2013 - 8:56am
tags:
Arena Pharmaceuticals, Europe, Belviq, earnings, Vivus
Gilead's HCV Drug Pipeline Outshines Weak Q1 Results
Investors.com
Friday, May 3, 2013 - 8:54am
tags:
earnings, Gilead, hepatitis C
Analysts drop Arena Pharma stock price targets as drugmaker withdraws Belviq application in EU
Yahoo/AP
Friday, May 3, 2013 - 8:53am
tags:
Belviq, Europe, Arena Pharmaceuticals
The Market's Got This Biotech All Wrong
Motley Fool
Friday, May 3, 2013 - 8:52am
tags:
Questcor, biotech, earnings
Regeneron acquires full rights to two novel development programs from Sanofi
Yahoo/Fly on the Wall
Friday, May 3, 2013 - 8:51am
tags:
Sanofi, Regeneron, ANG2, PDGF
The New Abbott Labs Is Leaner, but Needs Better Execution
TheStreet.com
Friday, May 3, 2013 - 8:49am
tags:
Abbott Laboratories, AbbVie, JNJ
Zogenix Poised For 40% Haircut As Zohydro Decision Approaches
Seeking Alpha
Friday, May 3, 2013 - 8:47am
tags:
Zogenix, Zohydro ER, painkillers
A.P. Pharma: Management Change Is A Positive For The Stock
Seeking Alpha
Friday, May 3, 2013 - 8:46am
tags:
AP Pharma
EPO Pills: A Challenge For Amgen And Johnson & Johnson
Seeking Alpha
Thursday, May 2, 2013 - 3:50pm
tags:
JNJ, Amgen, Aranesp, Procrit, Epogen
Elan considered buying Royalty before becoming its target
Reuters
Thursday, May 2, 2013 - 3:48pm
tags:
Elan, Royalty Pharma, M&A
Aveo Gets Bad News On Tivozanib
Seeking Alpha
Thursday, May 2, 2013 - 3:42pm
tags:
tivozanib, Aveo Oncology
Merck buddies up to Scripps spinout Abide in $430M diabetes partnership
Fierce Biotech
Thursday, May 2, 2013 - 10:55am
tags:
Scripps Health, Merck, diabetes, Abide
Aveo, Delcath FDA Panel Live Blog
TheStreet.com
Thursday, May 2, 2013 - 10:52am
tags:
FDA, advisory panels, tivozanib, Delcath, Aveo Oncology, kidney cancer, Melblez
Royalty Pharma stands by reduced Elan bid
Reuters
Thursday, May 2, 2013 - 10:49am
tags:
Royalty Pharma, M&A, Elan
Hyperion Therapeutics receives orphan drug exclusivity from FDA
Yahoo/Fly on the Wall
Thursday, May 2, 2013 - 10:48am
tags:
FDA, Hyperion Therapeutics, orphan drugs, Ravicti
Glaxo Mined Online Parent Discussion Boards For Vaccine Worries
WSJ Online
Thursday, May 2, 2013 - 10:45am
tags:
GSK, vaccines, message boards, social media, text analytics
Lpath: The Leader In Lipidomics
Seeking Alpha
Thursday, May 2, 2013 - 10:43am
tags:
Lpath, monoclonal antibodies
A Sweeter Deal On The Horizon For Prolor Biotech?
Seeking Alpha
Thursday, May 2, 2013 - 10:42am
tags:
Prolor Biotech, OPKO Health
Takeda Gets $6.5 Million Diabetes-Drug Verdict Thrown Out
Bloomberg
Thursday, May 2, 2013 - 10:38am
tags:
diabetes, Takeda, Actos, bladder cancer
Novartis Unloads OTC Products Made At Troubled Nebraska Plant
Pharmalot
Thursday, May 2, 2013 - 10:37am
tags:
OTC, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.